FineHeart Secures €83 Million to Support Its Growth and Establish Itself as a Future European Leader in Active Implantable Medical Devices (AIMDs)

FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announced today the completion…

BORDEAUX, France–(BUSINESS WIRE)–FineHeart, a clinical-stage medical technology company specializing in the development of innovative solutions for cardiology, announced today the completion of a €35 million first closing of its Series C financing … [5141 chars]

Source: Business Wire | Published: 2026-01-08T23:03:00Z

Credit: Business Wire